
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Everything you wanted to know from your customers and are ready to ask.
over 25 years ago
The Power of Public Relationsover 25 years ago
World-Class Marketing Plansover 25 years ago
How to Win Friends and Influence R&Dover 25 years ago
Working with an Agencyover 25 years ago
A Strategic Overviewover 25 years ago
The Regulatory Environment





